Menarini, Silicon

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Menarini Silicon Biosystems United Kingdom United States of America Canada Germany Spain France

View original content:https://www.prnewswire.co.uk/news-releases/menarini-silicon-biosystems-announces-publication-of-the-detect-iii-trial-results-highlighting-the-potential-clinical-utility-of-her2-testing-in-circulating-tumor-cells-with-cellsearch-302029601.html

en | boerse | 68000277 |